200 related articles for article (PubMed ID: 15322215)
1. 15-deoxy-Delta12,14-prostaglandin J2 inhibits IFN-inducible protein 10/CXC chemokine ligand 10 expression in human microglia: mechanisms and implications.
Si Q; Zhao ML; Morgan AC; Brosnan CF; Lee SC
J Immunol; 2004 Sep; 173(5):3504-13. PubMed ID: 15322215
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of LPS-induced chemokine KC expression by 15-deoxy-delta12,14-prostaglandin J2 in mouse peritoneal macrophages.
Kim HY; Kim HK; Kim JR; Kim HS
Immunol Cell Biol; 2005 Jun; 83(3):286-93. PubMed ID: 15877607
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of MIP-2 (CXCL2) expression by 15-deoxy-Delta(12,14)-prostaglandin J(2) in mouse peritoneal macrophages.
Kim HY; Kim HS
Immunol Cell Biol; 2007 Jan; 85(1):60-7. PubMed ID: 17130903
[TBL] [Abstract][Full Text] [Related]
4. 15-Deoxy-delta12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes.
Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon H; Um JW; Sohn J; Song GG; Ji JD
Exp Mol Med; 2005 Jun; 37(3):179-85. PubMed ID: 16000871
[TBL] [Abstract][Full Text] [Related]
5. The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1.
Jung WK; Park IS; Park SJ; Yea SS; Choi YH; Oh S; Park SG; Choi IW
Life Sci; 2009 Jul; 85(1-2):46-53. PubMed ID: 19409914
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of cyclooxygenase-2 expression by 15-deoxy-Delta(12,14)(12,14)-prostaglandin J(2) in activated human astrocytes, but not in human brain macrophages.
Janabi N
J Immunol; 2002 May; 168(9):4747-55. PubMed ID: 11971025
[TBL] [Abstract][Full Text] [Related]
7. Effect of 15-deoxy-delta12,14-prostaglandin J2 on IL-1beta-induced expression of epithelial neutrophil-activating protein-78 in human endothelial cells.
Imaizumi T; Kumagai M; Hatakeyama M; Tamo W; Yamashita K; Yoshida H; Munakata H; Satoh K
Prostaglandins Leukot Essent Fatty Acids; 2003 Nov; 69(5):323-7. PubMed ID: 14580366
[TBL] [Abstract][Full Text] [Related]
8. Cyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis.
Storer PD; Xu J; Chavis JA; Drew PD
J Neurosci Res; 2005 Apr; 80(1):66-74. PubMed ID: 15723383
[TBL] [Abstract][Full Text] [Related]
9. 15-deoxy-Delta12,14-prostaglandin J2 inhibits INF-gamma-induced JAK/STAT1 signalling pathway activation and IP-10/CXCL10 expression in mesangial cells.
Panzer U; Zahner G; Wienberg U; Steinmetz OM; Peters A; Turner JE; Paust HJ; Wolf G; Stahl RA; Schneider A
Nephrol Dial Transplant; 2008 Dec; 23(12):3776-85. PubMed ID: 18596134
[TBL] [Abstract][Full Text] [Related]
10. 15-deoxy-delta12,14-prostaglandin J2-mediated ERK signaling inhibits gram-negative bacteria-induced RelA phosphorylation and interleukin-6 gene expression in intestinal epithelial cells through modulation of protein phosphatase 2A activity.
Ruiz PA; Kim SC; Sartor RB; Haller D
J Biol Chem; 2004 Aug; 279(34):36103-11. PubMed ID: 15199053
[TBL] [Abstract][Full Text] [Related]
11. The 15-deoxy-δ12,14-prostaglandin J2 inhibits LPS‑stimulated inflammation via enhancement of the platelet‑activating factor acetylhydrolase activity in human retinal pigment epithelial cells.
Jung WK; Lee CM; Lee DS; Na G; Lee DY; Choi I; Park SG; Seo SK; Yang JW; Choi JS; Lee YM; Park WS; Choi IW
Int J Mol Med; 2014 Feb; 33(2):449-56. PubMed ID: 24337644
[TBL] [Abstract][Full Text] [Related]
12. 15-Deoxy-Delta(12,14)-prostaglandin J(2) and troglitazone regulation of the release of phospholipid metabolites, inflammatory cytokines and proteases from human gestational tissues.
Lappas M; Permezel M; Rice GE
Placenta; 2006; 27(11-12):1060-72. PubMed ID: 16434095
[TBL] [Abstract][Full Text] [Related]
13. Cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) acts as a general inhibitor of inflammatory responses in activated BV-2 microglial cells.
Koppal T; Petrova TV; Van Eldik LJ
Brain Res; 2000 Jun; 867(1-2):115-21. PubMed ID: 10837804
[TBL] [Abstract][Full Text] [Related]
14. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B.
Berry EB; Keelan JA; Helliwell RJ; Gilmour RS; Mitchell MD
Mol Pharmacol; 2005 Jul; 68(1):169-78. PubMed ID: 15821150
[TBL] [Abstract][Full Text] [Related]
15. Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions.
Bernardo A; Levi G; Minghetti L
Eur J Neurosci; 2000 Jul; 12(7):2215-23. PubMed ID: 10947800
[TBL] [Abstract][Full Text] [Related]
16. 15-Deoxy-{delta}12,14-prostaglandin j2 inhibits interleukin-1{beta}-induced nuclear factor-{kappa}b in human amnion and myometrial cells: mechanisms and implications.
Lindström TM; Bennett PR
J Clin Endocrinol Metab; 2005 Jun; 90(6):3534-43. PubMed ID: 15755849
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG
Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
[TBL] [Abstract][Full Text] [Related]
18. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma.
Giri S; Rattan R; Singh AK; Singh I
J Immunol; 2004 Oct; 173(8):5196-208. PubMed ID: 15470065
[TBL] [Abstract][Full Text] [Related]
19. 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.
Straus DS; Pascual G; Li M; Welch JS; Ricote M; Hsiang CH; Sengchanthalangsy LL; Ghosh G; Glass CK
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4844-9. PubMed ID: 10781090
[TBL] [Abstract][Full Text] [Related]
20. S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2).
Kielian T; McMahon M; Bearden ED; Baldwin AC; Drew PD; Esen N
J Neurochem; 2004 Sep; 90(5):1163-72. PubMed ID: 15312171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
